Evidence map›Paper›PMID 39129597›Full record

ArticleStroke2024

Loss of TGFβ-Mediated Repression of Angiopoietin-2 in Pericytes Underlies Germinal Matrix Hemorrhage Pathogenesis.

Jui M Dave, Raja Chakraborty, Alex Agyemang, Aglaia Ntokou, Junichi Saito, Praveen Ballabh, Kathleen A Martin, Daniel M Greif

Abstract read
In one paragraph

Article in Stroke, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jui M DaveDepartment of Internal Medicine, Yale Cardiovascular Research Center, Section of Cardiovascular Medicine (J.M.D., R.C., A.N., J.S., K.A.M., D.M.G.), Yale University, New Haven, CT.ORCID 0000-0002-5448-4798
Raja ChakrabortyDepartment of Internal Medicine, Yale Cardiovascular Research Center, Section of Cardiovascular Medicine (J.M.D., R.C., A.N., J.S., K.A.M., D.M.G.), Yale University, New Haven, CT.
Alex AgyemangDepartment of Pediatrics (A.A., P.B.), Albert Einstein College of Medicine, Bronx, NY.ORCID 0009-0003-9956-9175
Aglaia NtokouDepartment of Internal Medicine, Yale Cardiovascular Research Center, Section of Cardiovascular Medicine (J.M.D., R.C., A.N., J.S., K.A.M., D.M.G.), Yale University, New Haven, CT.ORCID 0000-0002-5272-580X
Junichi SaitoDepartment of Internal Medicine, Yale Cardiovascular Research Center, Section of Cardiovascular Medicine (J.M.D., R.C., A.N., J.S., K.A.M., D.M.G.), Yale University, New Haven, CT.ORCID 0000-0002-4297-727X
Praveen BallabhDepartment of Pediatrics (A.A., P.B.), Albert Einstein College of Medicine, Bronx, NY.ORCID 0000-0002-2387-3942
Kathleen A MartinDepartment of Internal Medicine, Yale Cardiovascular Research Center, Section of Cardiovascular Medicine (J.M.D., R.C., A.N., J.S., K.A.M., D.M.G.), Yale University, New Haven, CT.ORCID 0000-0002-1748-0034
Daniel M GreifDepartment of Internal Medicine, Yale Cardiovascular Research Center, Section of Cardiovascular Medicine (J.M.D., R.C., A.N., J.S., K.A.M., D.M.G.), Yale University, New Haven, CT.ORCID 0000-0002-9842-3751

Funding

Novel vascular smooth muscle cell progenitors in development and diseaseR35HL150766 · NHLBI · YALE UNIVERSITY · PI Daniel Greif · 2020 to 2026
$7.0M
Therapeutics Development Core (Core B)P30DK114857 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GEORGE, ALFRED L., QUAGGIN, SUSAN E. · 2018 to 2022
$5.7M
Intraventricular Hemorrhage Disrupts the Blood Brain Barrier in Premature InfantsR01NS117390 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI BALLABH, PRAVEEN · 2021 to 2025
$2.7M
Epigenetic-mediated Notch pathway activation promotes elastin aortopathyR01HD110059 · NICHD · YALE UNIVERSITY · PI Daniel Greif, Kathleen Ann Martin · 2023 to 2026
$2.6M
Role of LMO7 in atherosclerosisR01HL151222 · NHLBI · YALE UNIVERSITY · PI MARTIN, KATHLEEN ANN · 2020 to 2023
$2.2M
Coordinated regulation of vascular smooth muscle phenotype by p300, CBP, and TET2R01HL146101 · NHLBI · YALE UNIVERSITY · PI GALLAGHER, PATRICK G, MARTIN, KATHLEEN ANN · 2019 to 2022
$2.2M
Intraventricular Hemorrhage Affects Production of Cortical InterneuronsR01NS110760 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI BALLABH, PRAVEEN · 2019 to 2023
$1.8M
Pericyte angiopoietin2 and neonatal intracranial hemorrhageR21NS123469 · NINDS · YALE UNIVERSITY · PI GREIF, DANIEL · 2021 to 2021
$461k
Mural cell TGF-beta-mediated signaling and neonatal intracerebral hemorrhageR21NS088854 · NINDS · YALE UNIVERSITY · PI GREIF, DANIEL · 2014 to 2015
$458k
NHLBI NIH HHS R01 HL146101NHLBI NIH HHS R01 HL151222NHLBI NIH HHS R35 HL150766NICHD NIH HHS R01 HD110059NIDDK NIH HHS P30 DK114857NINDS NIH HHS R01 NS110760NINDS NIH HHS R01 NS117390NINDS NIH HHS R21 NS088854NINDS NIH HHS R21 NS123469
6 · The paper itself

Abstract

backgroundTGF (transforming growth factor)-β pathway is central to blood-brain barrier development as it regulates cross talk between pericytes and endothelial cells. Murine embryos lacking TGFβ receptor

methodsTranscriptomic analysis of human brain pericytes with ALK5 silencing identified differential gene expression. Brain vascular cells isolated from mutant embryonic mice with GMH-IVH and preterm human IVH brain samples were utilized for target validation. Finally, pharmacological and genetic inhibition was used to study the therapeutic effects on GMH-IVH pathology.

resultsHerein, we establish that the TGFβ/ALK5 pathway robustly represses ANGPT2 (angiopoietin-2) in pericytes via epigenetic remodeling. TGFβ-driven SMAD (suppressor of mothers against decapentaplegic) 3/4 associates with TGIF1 (TGFβ-induced factor homeobox 1) and HDAC (histone deacetylase) 5 to form a corepressor complex at the

conclusionsThis study demonstrates that TGFβ-mediated ANGPT2 repression in pericytes is critical for maintaining blood-brain barrier integrity and identifies pericyte-derived ANGPT2 as an important pathological target for GMH-IVH.

Indexed as

Angiopoietin-2PericytesTransforming Growth Factor betaAnimalsCerebral HemorrhageEndothelial CellsHumansMiceProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type ISignal TransductionAngiopoietin-2ANGPT2 protein, humanAngpt2 protein, mouseProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type ITgfbr1 protein, mouseTransforming Growth Factor betaangiogenesisangiopoietin-2blood-brain barrierendothelial cellsepigenomicsintrancranial hemorrhagespericytes

Identifiers

PMID39129597
PMCPMC11347087

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.